(R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of PAX3 mRNA CTD PMID:12739027 (S)-nicotine decreases expression ISO RGD:620431 6480464 Nicotine results in decreased expression of PAX3 mRNA CTD PMID:20339300 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of PAX3 mRNA CTD PMID:28960355 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PAX3 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620431 6480464 Tetrachlorodibenzodioxin results in increased expression of PAX3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1351352 6480464 Tetrachlorodibenzodioxin results in decreased expression of PAX3 mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1351352 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PAX3 mRNA] CTD PMID:11007951 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of PAX3 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of PAX3 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of PAX3 exon CTD PMID:33297965 5-bromo-2'-deoxyuridine increases response to substance EXP 6480464 PAX3 gene polymorphism results in increased susceptibility to Bromodeoxyuridine CTD PMID:3902948 5-fluorouracil decreases expression ISO RGD:1351352 6480464 Fluorouracil results in decreased expression of PAX3 mRNA CTD PMID:31711903 abacavir decreases expression ISO RGD:1351352 6480464 abacavir results in decreased expression of PAX3 mRNA CTD PMID:31711903 aflatoxin B1 decreases methylation ISO RGD:1351352 6480464 Aflatoxin B1 results in decreased methylation of PAX3 gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1351352 6480464 Aflatoxin B1 results in increased methylation of PAX3 exon, Aflatoxin B1 results in increased methylation of PAX3 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA], S-ethyl glutathione inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 aldehydo-D-glucose decreases expression ISO RGD:620431 6480464 Glucose results in decreased expression of PAX3 mRNA CTD PMID:21818840 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PAX3 mRNA CTD PMID:12739027 all-trans-retinoic acid multiple interactions ISO RGD:1351352 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:17229153 , PMID:31711903 all-trans-retinoic acid decreases expression ISO RGD:1351352 6480464 Tretinoin results in decreased expression of PAX3 mRNA CTD PMID:17229153 , PMID:21934132 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PAX3 mRNA CTD PMID:17038669 all-trans-retinoic acid increases response to substance EXP 6480464 PAX3 gene mutant form results in increased susceptibility to Tretinoin, PAX3 gene polymorphism results in increased susceptibility to Tretinoin CTD PMID:3902948 , PMID:6385329 all-trans-retinol multiple interactions ISO RGD:620431 6480464 Vitamin A inhibits the reaction [nitrofen results in decreased expression of PAX3 mRNA] CTD PMID:16481245 amiodarone increases expression ISO RGD:1351352 6480464 Amiodarone results in increased expression of PAX3 mRNA CTD PMID:19774075 ammonium chloride affects expression ISO RGD:620431 6480464 Ammonium Chloride affects the expression of PAX3 mRNA CTD PMID:16483693 ANTIMYCIN decreases expression EXP 6480464 antimycin results in decreased expression of PAX3 mRNA CTD PMID:12739027 arsenite(3-) increases methylation ISO RGD:1351352 6480464 arsenite results in increased methylation of PAX3 promoter CTD PMID:23974009 belinostat increases expression ISO RGD:1351352 6480464 belinostat results in increased expression of PAX3 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386 benzo[a]pyrene increases methylation ISO RGD:1351352 6480464 Benzo(a)pyrene results in increased methylation of PAX3 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1351352 6480464 Benzo(a)pyrene affects the methylation of PAX3 3' UTR, Benzo(a)pyrene affects the methylation of PAX3 promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1351352 6480464 Diethylhexyl Phthalate results in decreased expression of PAX3 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:620431 6480464 bisphenol A affects the expression of PAX3 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1351352 6480464 bisphenol A results in decreased methylation of PAX3 gene CTD PMID:31601247 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of PAX3 promoter CTD PMID:27334623 bisphenol F decreases expression EXP 6480464 bisphenol F results in decreased expression of PAX3 mRNA CTD PMID:30951980 bromobenzene decreases expression ISO RGD:620431 6480464 bromobenzene results in decreased expression of PAX3 mRNA CTD PMID:32479839 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of PAX3 mRNA CTD PMID:25149082 cadmium atom decreases activity EXP 6480464 Cadmium results in decreased activity of PAX3 protein CTD PMID:33642518 cadmium sulfate increases response to substance EXP 6480464 PAX3 gene polymorphism results in increased susceptibility to cadmium sulfate CTD PMID:3902948 caffeine decreases expression ISO RGD:1351352 6480464 Caffeine results in decreased expression of PAX3 mRNA CTD PMID:31711903 CGP 52608 multiple interactions ISO RGD:1351352 6480464 CGP 52608 promotes the reaction [RORA protein binds to PAX3 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:1351352 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:31711903 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX3 gene CTD PMID:20938992 copper(II) sulfate decreases expression ISO RGD:1351352 6480464 Copper Sulfate results in decreased expression of PAX3 mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO RGD:1351352 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PAX3 mRNA] CTD PMID:11007951 D-glucose multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA], S-ethyl glutathione inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 D-glucose decreases expression ISO RGD:620431 6480464 Glucose results in decreased expression of PAX3 mRNA CTD PMID:21818840 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PAX3 mRNA CTD PMID:12739027 dabigatran decreases expression ISO RGD:1351352 6480464 Dabigatran results in decreased expression of PAX3 mRNA CTD PMID:31711903 dexamethasone affects expression ISO RGD:1351352 6480464 Dexamethasone affects the expression of PAX3 mRNA CTD PMID:34742744 dorsomorphin multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression ISO RGD:620431 6480464 Endosulfan results in decreased expression of PAX3 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1351352 6480464 entinostat results in increased expression of PAX3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386 ethylene glycol decreases expression ISO RGD:1351352 6480464 Ethylene Glycol results in decreased expression of PAX3 mRNA CTD PMID:31711903 fluoxetine affects expression EXP 6480464 Fluoxetine affects the expression of PAX3 mRNA CTD PMID:29893963 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX3 gene CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of PAX3 mRNA CTD PMID:25629700 folic acid decreases expression ISO RGD:1351352 6480464 Folic Acid results in decreased expression of PAX3 mRNA CTD PMID:21867686 furan decreases expression ISO RGD:620431 6480464 furan results in decreased expression of PAX3 mRNA CTD PMID:25539665 gentamycin increases expression ISO RGD:620431 6480464 Gentamicins results in increased expression of PAX3 mRNA CTD PMID:33387578 glucose multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA], S-ethyl glutathione inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 glucose decreases expression ISO RGD:620431 6480464 Glucose results in decreased expression of PAX3 mRNA CTD PMID:21818840 glucose decreases expression EXP 6480464 Glucose results in decreased expression of PAX3 mRNA CTD PMID:12739027 Glutathione ethyl ester multiple interactions EXP 6480464 S-ethyl glutathione inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 glycolic acid decreases expression ISO RGD:1351352 6480464 glycolic acid results in decreased expression of PAX3 mRNA CTD PMID:31711903 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX3 gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:1351352 6480464 [S-(1 more ... CTD PMID:35811015 lithium chloride increases expression ISO RGD:1351352 6480464 Lithium Chloride results in increased expression of PAX3 protein CTD PMID:19101580 methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of PAX3 mRNA CTD PMID:21613230 methylmercury chloride decreases expression ISO RGD:1351352 6480464 methylmercuric chloride results in decreased expression of PAX3 mRNA CTD PMID:28001369 , PMID:34328791 methylparaben increases expression EXP 6480464 methylparaben results in increased expression of PAX3 mRNA CTD PMID:28927898 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1351352 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PAX3 mRNA CTD PMID:31711903 N,N-diethyl-m-toluamide multiple interactions ISO RGD:620431 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PAX3 gene CTD PMID:33148267 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of PAX3 gene CTD PMID:16724327 nicotine decreases expression ISO RGD:620431 6480464 Nicotine results in decreased expression of PAX3 mRNA CTD PMID:20339300 nilotinib decreases expression ISO RGD:1351352 6480464 nilotinib results in decreased expression of PAX3 mRNA CTD PMID:31711903 nitrofen decreases expression ISO RGD:620431 6480464 nitrofen results in decreased expression of PAX3 mRNA CTD PMID:15616818 , PMID:16481245 nitrofen multiple interactions ISO RGD:620431 6480464 Vitamin A inhibits the reaction [nitrofen results in decreased expression of PAX3 mRNA] CTD PMID:16481245 panobinostat multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1351352 6480464 panobinostat results in increased expression of PAX3 mRNA CTD PMID:26272509 permethrin multiple interactions ISO RGD:620431 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PAX3 gene CTD PMID:33148267 phenylmercury acetate increases expression ISO RGD:1351352 6480464 Phenylmercuric Acetate results in increased expression of PAX3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of PAX3 mRNA CTD PMID:9118846 phenytoin decreases expression ISO RGD:1351352 6480464 Phenytoin results in decreased expression of PAX3 mRNA CTD PMID:31711903 propanal decreases expression ISO RGD:1351352 6480464 propionaldehyde results in decreased expression of PAX3 mRNA CTD PMID:26079696 Ptaquiloside decreases expression EXP 6480464 ptaquiloside results in decreased expression of PAX3 mRNA CTD PMID:23274088 resveratrol multiple interactions ISO RGD:1351352 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PAX3 mRNA CTD PMID:23557933 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1351352 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of PAX3 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1351352 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1351352 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:31711903 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PAX3 mRNA, sodium arsenite results in decreased expression of PAX3 protein CTD PMID:22641621 , PMID:26024302 sodium arsenite affects methylation ISO RGD:1351352 6480464 sodium arsenite affects the methylation of PAX3 gene CTD PMID:28589171 stilbenoid decreases expression EXP 6480464 Stilbenes analog results in decreased expression of PAX3 mRNA CTD PMID:29042215 streptomycin multiple interactions ISO RGD:1351352 6480464 [Penicillins co-treated with Streptomycin] results in increased expression of PAX3 mRNA CTD PMID:31711903 sunitinib increases expression ISO RGD:1351352 6480464 Sunitinib results in increased expression of PAX3 mRNA CTD PMID:31533062 thalidomide decreases expression ISO RGD:1351352 6480464 Thalidomide results in decreased expression of PAX3 mRNA CTD PMID:31711903 trichostatin A increases expression ISO RGD:1351352 6480464 trichostatin A results in increased expression of PAX3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1351352 6480464 Valproic Acid results in increased expression of PAX3 mRNA, Valproic Acid results in increased expression of PAX3 protein CTD PMID:19101580 more ... valproic acid decreases expression ISO RGD:1351352 6480464 Valproic Acid results in decreased expression of PAX3 mRNA CTD PMID:28001369 , PMID:31711903 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PAX3 mRNA CTD PMID:31445079 valproic acid multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1351352 6480464 vorinostat results in increased expression of PAX3 mRNA CTD PMID:26272509 vorinostat decreases expression ISO RGD:1351352 6480464 vorinostat results in decreased expression of PAX3 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:1351352 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX3 mRNA CTD PMID:27188386